PRME Q2 2024 Earnings — Prime Medicine, Inc. Revenue & Financial Results | Market Cap Arena

PRMEPrime Medicine, Inc.

$771M

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$56M

Net Income

-$55M

EPS (Diluted)

$-0.46

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$45M

Free Cash Flow

-$47M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$260M

Total Liabilities

$63M

Stockholders' Equity

$197M

Cash & Equivalents

$56M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$56M	-$45M	-23.0%
Net Income	-$55M	-$42M	-30.5%